COCO director Sadowsky reports 3,900-share sale, holds 616K shares

Rhea-AI Filing Summary

Vita Coco Company, Inc. (COCO) director Kenneth Sadowsky reported selling 3,900 shares of common stock on 11/19/2025 in an open-market transaction coded as “S.” The weighted average sale price was $47.115 per share, with individual trades executed between $46.32 and $47.45. The filing notes these sales were made under a pre-arranged Rule 10b5-1 trading plan. After this transaction, Sadowsky beneficially owns 616,066 Vita Coco common shares directly. He also holds a non-qualified stock option to purchase 27,300 shares at an exercise price of $10.178 per share, which is fully vested and exercisable and expires on 01/02/2030.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sadowsky Kenneth

(Last) (First) (Middle)

111 5TH AVENUE

2ND FLOOR

(Street)

NEW YORK NY 10003

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/19/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/19/2025		S(1)		3,900	D	$47.115(2)	616,066	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$10.178							(3)	01/02/2030	Common Stock	27,300		27,300	D

Explanation of Responses:

1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.32 to $47.45, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

3. The stock option is fully vested and currently exercisable.

	By: Alison Klein, Attorney-in-Fact For: Kenneth Sadowsky	11/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Vita Coco (COCO) report in this Form 4?

The Form 4 reports that director Kenneth Sadowsky sold 3,900 shares of Vita Coco common stock on 11/19/2025 in an open-market sale coded as “S.”

At what price did the Vita Coco (COCO) director sell his shares?

The weighted average sale price was $47.115 per share, with individual trades executed at prices ranging from $46.32 to $47.45, inclusive.

How many Vita Coco (COCO) shares does the reporting person own after the sale?

Following the reported transaction, Kenneth Sadowsky beneficially owns 616,066 shares of Vita Coco common stock, held directly.

Was the Vita Coco (COCO) share sale made under a Rule 10b5-1 plan?

Yes. The filing states that the sales of common stock were effected pursuant to a Rule 10b5-1 trading plan for pre-arranged transactions.

What stock options related to Vita Coco (COCO) does the director hold?

He holds a non-qualified stock option to buy 27,300 Vita Coco shares at an exercise price of $10.178 per share. The option is fully vested, currently exercisable, and expires on 01/02/2030.

Is the Form 4 for Vita Coco (COCO) filed by a single reporting person?

Yes. The Form 4 indicates it is filed by one reporting person, namely director Kenneth Sadowsky.